Insider Transactions in Q1 2025 at Hca Healthcare, Inc. (HCA)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 14
2025
|
Jennifer Berres SVP & Chief Human Res. Officer |
SELL
Open market or private sale
|
Direct |
9,533
-21.26%
|
$3,069,626
$322.63 P/Share
|
|
Feb 13
2025
|
Sammie S Mosier SVP & Chief Nurse Executive |
SELL
Payment of exercise price or tax liability
|
Direct |
227
-2.0%
|
$72,867
$321.92 P/Share
|
|
Feb 13
2025
|
Sammie S Mosier SVP & Chief Nurse Executive |
BUY
Grant, award, or other acquisition
|
Direct |
845
+6.93%
|
-
|
|
Feb 13
2025
|
Christopher F. Wyatt SVP & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
227
-0.55%
|
$72,867
$321.92 P/Share
|
|
Feb 13
2025
|
Christopher F. Wyatt SVP & Controller |
BUY
Grant, award, or other acquisition
|
Direct |
845
+2.01%
|
-
|
|
Feb 13
2025
|
Samuel N Hazen CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,742
-6.21%
|
$1,522,182
$321.92 P/Share
|
|
Feb 13
2025
|
Samuel N Hazen CEO |
BUY
Grant, award, or other acquisition
|
Direct |
13,218
+14.75%
|
-
|
|
Feb 13
2025
|
Mike A Marks EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
172
-26.96%
|
$55,212
$321.92 P/Share
|
|
Feb 13
2025
|
Mike A Marks EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
638
+50.0%
|
-
|
|
Feb 13
2025
|
Michael R Mc Alevey EVP & Chief Legal & Admin Off. |
SELL
Payment of exercise price or tax liability
|
Direct |
531
-16.45%
|
$170,451
$321.92 P/Share
|
|
Feb 13
2025
|
Michael R Mc Alevey EVP & Chief Legal & Admin Off. |
BUY
Grant, award, or other acquisition
|
Direct |
2,117
+39.61%
|
-
|
|
Feb 13
2025
|
Michael S. Cuffe EVP and Chief Clinical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
583
-1.82%
|
$187,143
$321.92 P/Share
|
|
Feb 13
2025
|
Michael S. Cuffe EVP and Chief Clinical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,330
+6.79%
|
-
|
|
Feb 13
2025
|
Jon M Foster EVP and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
684
-2.36%
|
$219,564
$321.92 P/Share
|
|
Feb 13
2025
|
Jon M Foster EVP and COO |
BUY
Grant, award, or other acquisition
|
Direct |
2,750
+8.65%
|
-
|
|
Feb 13
2025
|
Jennifer Berres SVP & Chief Human Res. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
407
-1.61%
|
$130,647
$321.92 P/Share
|
|
Feb 13
2025
|
Jennifer Berres SVP & Chief Human Res. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,588
+5.89%
|
-
|
|
Feb 07
2025
|
Jennifer Berres SVP & Chief Human Res. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,747
-22.11%
|
$2,172,534
$322.05 P/Share
|
|
Feb 07
2025
|
Jennifer Berres SVP & Chief Human Res. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,780
+17.29%
|
$1,413,600
$120.11 P/Share
|
|
Feb 03
2025
|
Sammie S Mosier SVP & Chief Nurse Executive |
SELL
Payment of exercise price or tax liability
|
Direct |
41
-0.39%
|
$13,694
$334.3 P/Share
|
|
Feb 03
2025
|
Sammie S Mosier SVP & Chief Nurse Executive |
BUY
Exercise of conversion of derivative security
|
Direct |
138
+1.29%
|
-
|